High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity

Am J Physiol Renal Physiol. 2010 Sep;299(3):F656-63. doi: 10.1152/ajprenal.00047.2010. Epub 2010 Jul 7.

Abstract

A deficiency in nitric oxide (NO) generation leads to salt-sensitive hypertension, but the role of increased superoxide (O(2)(-)) in such salt sensitivity has not been delineated. We examined the hypothesis that an enhancement in O(2)(-) activity induced by high-salt (HS) intake under deficient NO production contributes to the development of salt-sensitive hypertension. Endothelial NO synthase knockout (eNOS KO; total n = 64) and wild-type (WT; total n = 58) mice were given diets containing either normal (NS; 0.4%) or high-salt (HS; 4%) for 2 wk. During this period, mice were chronically treated with a O(2)(-) scavenger, tempol (400 mg/l), or an inhibitor of NADPH oxidase, apocynin (1 g/l), in drinking water or left untreated (n = 6-8 per group). Blood pressure was measured by radiotelemetry and 24-h urine samples were collected in metabolic cages. Basal mean arterial pressure (MAP) in eNOS KO was higher (125 +/- 4 vs. 106 +/- 3 mmHg) compared with WT. Feeding HS diet did not alter MAP in WT but increased it in eNOS KO to 166 +/- 9 mmHg. Both tempol and apocynin treatment significantly attenuated the MAP response to HS in eNOS KO (134 +/- 3 and 139 +/- 4 mmHg, respectively). Basal urinary 8-isoprostane excretion rates (U(Iso)V), a marker for endogenous O(2)(-) activity, were similar (2.8 +/- 0.2 and 2.4 +/- 0.3 ng/day) in both eNOS KO and WT mice. However, HS increased U(Iso)V more in eNOS KO than in WT (4.6 +/- 0.3 vs. 3.8 +/- 0.2 ng/day); these were significantly attenuated by both tempol and apocynin treatment. These data indicate that an enhancement in O(2)(-) activity contributes substantially to the development of salt-sensitive hypertension under NO-deficient conditions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Animals
  • Antioxidants / pharmacology
  • Blood Pressure / drug effects
  • Cyclic N-Oxides / pharmacology
  • Dinoprost / analogs & derivatives
  • Dinoprost / urine
  • Disease Models, Animal
  • Hypertension / etiology*
  • Hypertension / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism*
  • Sodium Chloride, Dietary / adverse effects
  • Sodium Chloride, Dietary / pharmacology*
  • Spin Labels
  • Superoxides / metabolism*

Substances

  • Acetophenones
  • Antioxidants
  • Cyclic N-Oxides
  • Sodium Chloride, Dietary
  • Spin Labels
  • Superoxides
  • 8-epi-prostaglandin F2alpha
  • acetovanillone
  • Dinoprost
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • tempol